Guidelines for the standardized collection of blood-based biomarkers in psychiatry: Steps for laboratory validity–a consensus of the Biomarkers Task Force from the WFSBP

Ana C. Andreazza, Isabelle Laksono, Brisa S. Fernandes, Catherine Toben, Piotr Lewczuk, Peter Riederer, Sidney H. Kennedy, Dimitrios Kapogiannis, Florence Thibaut, Manfred Gerlach, Carla Gallo, Yong Ku Kim, Edna Grünblatt, Lakshmi Yatham, Michael Berk, Bernhard T. Baune

Research output: Contribution to journalReview article

Abstract

Recently, there has been a major shift in the field of psychiatry towards the exploration of complex relationships between blood-based biomarkers and the pathophysiology of psychiatric and neuropsychiatric disorders. However, issues with study reproducibility, validity and reliability have hindered progress towards the identification of clinically relevant biomarkers for psychiatry. The achievement of laboratory validity is a crucial first step for the posterior development of clinical validity. There is evidence that the variability observed in blood-based research studies may be minimised with the implementation of standardised pre-analytical methods and uniform clinical protocols (i.e., pre-venipuncture). It has been documented that errors made in the pre-analytical phase account for 46–68.2% of laboratory testing errors. Thus, standardising clinical assessment, ethical procedures and pre-analytical phase of clinical research is essential for the reproducibility, validity and reliability of blood marker assessment, and reducing the risk of invalid test results. Various other areas of research have already moved towards guidelines for the standardised collection of blood-based biomarkers. Here we aim to provide a set of guidelines that we believe would improve biomarker research: (1) pre-venipuncture information and documentation, (2) ethics of participant consent and (3) pre-analytical methods. Ultimately, we hope this will assist study planning and will improve data comparison across studies allowing for the discovery of biomarkers in psychiatry with both laboratorial and clinical validity.

Original languageEnglish
JournalWorld Journal of Biological Psychiatry
DOIs
Publication statusPublished - 2019 Jan 1

Fingerprint

Advisory Committees
Psychiatry
Consensus
Biomarkers
Guidelines
Phlebotomy
Research
Reproducibility of Results
Clinical Protocols
Ethics
Documentation

Keywords

  • Biomarkers
  • guidelines
  • reliability
  • standardisation
  • validity

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Guidelines for the standardized collection of blood-based biomarkers in psychiatry : Steps for laboratory validity–a consensus of the Biomarkers Task Force from the WFSBP. / Andreazza, Ana C.; Laksono, Isabelle; Fernandes, Brisa S.; Toben, Catherine; Lewczuk, Piotr; Riederer, Peter; Kennedy, Sidney H.; Kapogiannis, Dimitrios; Thibaut, Florence; Gerlach, Manfred; Gallo, Carla; Kim, Yong Ku; Grünblatt, Edna; Yatham, Lakshmi; Berk, Michael; Baune, Bernhard T.

In: World Journal of Biological Psychiatry, 01.01.2019.

Research output: Contribution to journalReview article

Andreazza, AC, Laksono, I, Fernandes, BS, Toben, C, Lewczuk, P, Riederer, P, Kennedy, SH, Kapogiannis, D, Thibaut, F, Gerlach, M, Gallo, C, Kim, YK, Grünblatt, E, Yatham, L, Berk, M & Baune, BT 2019, 'Guidelines for the standardized collection of blood-based biomarkers in psychiatry: Steps for laboratory validity–a consensus of the Biomarkers Task Force from the WFSBP', World Journal of Biological Psychiatry. https://doi.org/10.1080/15622975.2019.1574024
Andreazza, Ana C. ; Laksono, Isabelle ; Fernandes, Brisa S. ; Toben, Catherine ; Lewczuk, Piotr ; Riederer, Peter ; Kennedy, Sidney H. ; Kapogiannis, Dimitrios ; Thibaut, Florence ; Gerlach, Manfred ; Gallo, Carla ; Kim, Yong Ku ; Grünblatt, Edna ; Yatham, Lakshmi ; Berk, Michael ; Baune, Bernhard T. / Guidelines for the standardized collection of blood-based biomarkers in psychiatry : Steps for laboratory validity–a consensus of the Biomarkers Task Force from the WFSBP. In: World Journal of Biological Psychiatry. 2019.
@article{5d664ff7ecfa43ceb0451140d105e17b,
title = "Guidelines for the standardized collection of blood-based biomarkers in psychiatry: Steps for laboratory validity–a consensus of the Biomarkers Task Force from the WFSBP",
abstract = "Recently, there has been a major shift in the field of psychiatry towards the exploration of complex relationships between blood-based biomarkers and the pathophysiology of psychiatric and neuropsychiatric disorders. However, issues with study reproducibility, validity and reliability have hindered progress towards the identification of clinically relevant biomarkers for psychiatry. The achievement of laboratory validity is a crucial first step for the posterior development of clinical validity. There is evidence that the variability observed in blood-based research studies may be minimised with the implementation of standardised pre-analytical methods and uniform clinical protocols (i.e., pre-venipuncture). It has been documented that errors made in the pre-analytical phase account for 46–68.2{\%} of laboratory testing errors. Thus, standardising clinical assessment, ethical procedures and pre-analytical phase of clinical research is essential for the reproducibility, validity and reliability of blood marker assessment, and reducing the risk of invalid test results. Various other areas of research have already moved towards guidelines for the standardised collection of blood-based biomarkers. Here we aim to provide a set of guidelines that we believe would improve biomarker research: (1) pre-venipuncture information and documentation, (2) ethics of participant consent and (3) pre-analytical methods. Ultimately, we hope this will assist study planning and will improve data comparison across studies allowing for the discovery of biomarkers in psychiatry with both laboratorial and clinical validity.",
keywords = "Biomarkers, guidelines, reliability, standardisation, validity",
author = "Andreazza, {Ana C.} and Isabelle Laksono and Fernandes, {Brisa S.} and Catherine Toben and Piotr Lewczuk and Peter Riederer and Kennedy, {Sidney H.} and Dimitrios Kapogiannis and Florence Thibaut and Manfred Gerlach and Carla Gallo and Kim, {Yong Ku} and Edna Gr{\"u}nblatt and Lakshmi Yatham and Michael Berk and Baune, {Bernhard T.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1080/15622975.2019.1574024",
language = "English",
journal = "World Journal of Biological Psychiatry",
issn = "1562-2975",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Guidelines for the standardized collection of blood-based biomarkers in psychiatry

T2 - Steps for laboratory validity–a consensus of the Biomarkers Task Force from the WFSBP

AU - Andreazza, Ana C.

AU - Laksono, Isabelle

AU - Fernandes, Brisa S.

AU - Toben, Catherine

AU - Lewczuk, Piotr

AU - Riederer, Peter

AU - Kennedy, Sidney H.

AU - Kapogiannis, Dimitrios

AU - Thibaut, Florence

AU - Gerlach, Manfred

AU - Gallo, Carla

AU - Kim, Yong Ku

AU - Grünblatt, Edna

AU - Yatham, Lakshmi

AU - Berk, Michael

AU - Baune, Bernhard T.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Recently, there has been a major shift in the field of psychiatry towards the exploration of complex relationships between blood-based biomarkers and the pathophysiology of psychiatric and neuropsychiatric disorders. However, issues with study reproducibility, validity and reliability have hindered progress towards the identification of clinically relevant biomarkers for psychiatry. The achievement of laboratory validity is a crucial first step for the posterior development of clinical validity. There is evidence that the variability observed in blood-based research studies may be minimised with the implementation of standardised pre-analytical methods and uniform clinical protocols (i.e., pre-venipuncture). It has been documented that errors made in the pre-analytical phase account for 46–68.2% of laboratory testing errors. Thus, standardising clinical assessment, ethical procedures and pre-analytical phase of clinical research is essential for the reproducibility, validity and reliability of blood marker assessment, and reducing the risk of invalid test results. Various other areas of research have already moved towards guidelines for the standardised collection of blood-based biomarkers. Here we aim to provide a set of guidelines that we believe would improve biomarker research: (1) pre-venipuncture information and documentation, (2) ethics of participant consent and (3) pre-analytical methods. Ultimately, we hope this will assist study planning and will improve data comparison across studies allowing for the discovery of biomarkers in psychiatry with both laboratorial and clinical validity.

AB - Recently, there has been a major shift in the field of psychiatry towards the exploration of complex relationships between blood-based biomarkers and the pathophysiology of psychiatric and neuropsychiatric disorders. However, issues with study reproducibility, validity and reliability have hindered progress towards the identification of clinically relevant biomarkers for psychiatry. The achievement of laboratory validity is a crucial first step for the posterior development of clinical validity. There is evidence that the variability observed in blood-based research studies may be minimised with the implementation of standardised pre-analytical methods and uniform clinical protocols (i.e., pre-venipuncture). It has been documented that errors made in the pre-analytical phase account for 46–68.2% of laboratory testing errors. Thus, standardising clinical assessment, ethical procedures and pre-analytical phase of clinical research is essential for the reproducibility, validity and reliability of blood marker assessment, and reducing the risk of invalid test results. Various other areas of research have already moved towards guidelines for the standardised collection of blood-based biomarkers. Here we aim to provide a set of guidelines that we believe would improve biomarker research: (1) pre-venipuncture information and documentation, (2) ethics of participant consent and (3) pre-analytical methods. Ultimately, we hope this will assist study planning and will improve data comparison across studies allowing for the discovery of biomarkers in psychiatry with both laboratorial and clinical validity.

KW - Biomarkers

KW - guidelines

KW - reliability

KW - standardisation

KW - validity

UR - http://www.scopus.com/inward/record.url?scp=85063400328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063400328&partnerID=8YFLogxK

U2 - 10.1080/15622975.2019.1574024

DO - 10.1080/15622975.2019.1574024

M3 - Review article

C2 - 30907211

AN - SCOPUS:85063400328

JO - World Journal of Biological Psychiatry

JF - World Journal of Biological Psychiatry

SN - 1562-2975

ER -